Inventor
TELEHA CHRISTOPHER A
US22 patents
⚠️ This page may combine multiple inventors who share the name “TELEHA CHRISTOPHER A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DU PONT MERCK PHARMA
7 patentsUS5594001AJan 14, 1997
Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
DU PONT MERCK PHARMA26 citations92
US5296478AMar 22, 1994
1-substituted oxindoles as cognition enhancers
DU PONT MERCK PHARMA39 citations92
US5532249AJul 2, 1996
Disubstituted polycyclic systems as cognition enhancers
DU PONT MERCK PHARMA5 citations62
US5308851AMay 3, 1994
Bispyridyl-containing heterocycles useful for treating cognitive disorders
DU PONT MERCK PHARMA2 citations62
US5597916AJan 28, 1997
1 substituted oxindoles and azaoxindoles
DU PONT MERCK PHARMA0 citations52
US5519132AMay 21, 1996
Pyridine compounds
DU PONT MERCK PHARMA0 citations52
US5428035AJun 27, 1995
1-substituted azaoxindoles and pharmaceutical compositions
DU PONT MERCK PHARMA1 citations52
JANSSEN PHARMACEUTICA NV
4 patentsUS7994206B2Aug 9, 2011
Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
JANSSEN PHARMACEUTICA NV18 citations92
US9150532B2Oct 6, 2015
Fused cyclopentyl antagonists of CCR2
JANSSEN PHARMACEUTICA NV0 citations50
US9303046B2Apr 5, 2016
Process for the preparation of heterocyclic ester derivatives
JANSSEN PHARMACEUTICA NV1 citations48
US9029352B2May 12, 2015
Process for the preparation of C-FMS kinase inhibitors
JANSSEN PHARMACEUTICA NV0 citations33
FURIEX PHARMACEUTICALS INC
3 patentsUS9115091B2Aug 25, 2015
Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl—1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
FURIEX PHARMACEUTICALS INC11 citations91
US8859604B2Oct 14, 2014
Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
FURIEX PHARMACEUTICALS INC14 citations91
US8691860B2Apr 8, 2014
Crystals and process of making 5-({(2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(-4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
FURIEX PHARMACEUTICALS INC16 citations91
BRISTOL MYERS SQUIBB PHARMA CO
3 patentsUS6667332B2Dec 23, 2003
Efficient process for the preparation of a factor Xa inhibitor
BRISTOL MYERS SQUIBB PHARMA CO11 citations72
US6747158B2Jun 8, 2004
Efficient process for the preparation of a factor Xa inhibitor
BRISTOL MYERS SQUIBB PHARMA CO4 citations61
US6417394B2Jul 9, 2002
Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators
BRISTOL MYERS SQUIBB PHARMA CO1 citations46